Momelotinib Impurity 9 | CAS 1841094-22-1 - Request Quote
Momelotinib Impurity 9
| SZ CAT No: | SZ-M168019 |
| CAS No | 1841094-22-1 |
| Mol.F. | C21H18N6O2 |
| Mol.Wt. | 386.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Momelotinib Impurity 9 is chemically 4-(2-((4-Acetamidophenyl)amino)pyrimidin-4-yl)-N-(cyanomethyl)benzamide. Momelotinib Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Momelotinib Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Momelotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1841094-22-1
Purchase 1841094-22-1
Order 1841094-22-1
Enquire 1841094-22-1
price of 1841094-22-1
1841094-22-1 Supplier
1841094-22-1 Manufacturer
1841094-22-1 Exporter
buy high quality Momelotinib Impurity 9
Purchase Momelotinib Impurity 9
Momelotinib Impurity 9 suppliers
Momelotinib Impurity 9 manufacturers
Momelotinib Impurity 9 price
Order Momelotinib Impurity 9
Enquire Momelotinib Impurity 9
Momelotinib Impurity 9 cost
Momelotinib Impurity 9 Supplier
Momelotinib Impurity 9 Distributor
Momelotinib Impurity 9 for Method Validation
Momelotinib Reference Standard
Momelotinib Impurity 9 for ANDA Filing
Momelotinib Impurity 9 for Forced Degradation Studies
Momelotinib Impurity 9 Identification Standards
Momelotinib Impurity 9 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


